Investigators sought to determine the cost-effectiveness of home- versus clinic-based anal cancer screening for increasing uptake among sexual and gender minorities.
In this study, researchers evaluated patients who had incomplete cCRT or experienced progression during or within 42 days of receiving cCRT, with an aim of identifying risk factors for these outcomes.
Survival rates for all cancers are increasing, but threats to federal funding and access to care jeopardize these advances.
Investigators assessed whether anticoagulation and platelet aggregation inhibition could have antitumoral effects when used along side targeted therapies for patients with unresectable stage III-IV ...
Dr Andrew Howard, chairman and president of the Kidney Transplant Collaborative, told the Associated Press that the drop off in kidney transplants would have been larger if not for a small increase of ...
Researchers investigated whether the time interval between a positive FIT result and follow-up colonoscopy is linked to risk for CRC.
Investigators assessed the association between race, ethnicity and neighborhood-level SES with mortality among young adults with mCRC.
Investigators sought to describe the patterns of post-progression outcome for patients with HR+/HER2- advanced breast cancer treated with endocrine therapy and a CDK4/6 inhibitor.
Adding elraglusib to chemotherapy significantly increases overall survival in patients with previously untreated metastatic PDAC.
Investigators evaluated the association between risk-reducing bilateral mastectomy and overall and breast cancer–specific mortality in female carriers of BRCA pathogenic variants.
A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.
Quality communication about end-of-life care ensures that medical treatments or interventions align with patients’ values and preferences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results